Goldman Sachs

HDFC Asset Management Co is set to kick off investor education for its India IPO, according to a banker working on the deal.

Bank of the Philippine Islands has firmed up the launch date and number of shares for its Ps50bn ($961.5m) rights issue.

The going was heavy for dollar borrowers as investors demanded extra concessions amid poor performance as CVS Healthcare’s trade from the previous week appeared to re-price the market.

Financial institutions stretched the appetite of bond investors to breaking point this week, flooding the euro market with nearly €15bn of deals, which struggled to perform in secondary despite carrying large new issue concessions.

Corporate bond issuers who sold their deals earlier the week found execution much easier than those who came later in the week. Strong order books and single digit new issue premiums gave way to premiums of as much as 20bp and one deal having to be downsized.

Dutch supermarket operator Ahold Delhaize is becoming a frequent issuer, as it sold a dual tranche deal this week, six months after its return to the market from a five year absence.

UK media company WPP sold a dual tranche bond this week, following its own recent trend for issuing shorter tenors with its most recent euro issues.

Books closed on the IPO of Siemens Healthineers, the healthcare technology division of Siemens, on Thursday lunchtime, with the base deal valued at €3.65bn and the company at €28bn.

Swiss luxury goods company Richemont made its debut in the corporate bond market on Thursday with a jumbo triple tranche offering. And Goldman Sachs leapt in the league tables by solely running the €3.75bn deal.

Goldman Sachs was offering investors a large new issue premium in exchange for 10 year euro funding on Thursday, as trading levels suffered under the weight of recent primary market supply.

China-based GreenTree Hospitality Group has kicked off bookbuilding for an up to $349.2m IPO on the New York Stock Exchange, according to a filing with the US market regulator.

The botched succession to the chief executive seat is un-Goldmanlike, and the firm must provide more clarity if it is to stay focused on its expansion plans and not cede the initiative to its rivals, writes David Rothnie.